Severe esophagitis healed in less than a week with intravenous antoprazole [1]

Journal of Clinical Gastroenterology

Volumn 36, Issue 1, 2003, Pages 78-79

  Dabney Smith, Kila ^a   Nam, Jae ^a   Ghazale, Amaar ^a   Cai, Qiang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; CASE REPORT; CLINICAL FEATURE; ESOPHAGITIS; FEMALE; HEALING; HUMAN; LETTER; PRIORITY JOURNAL; STOMACH ACID SECRETION; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; BENZIMIDAZOLES; ENZYME INHIBITORS; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; H(+)-K(+)-EXCHANGING ATPASE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; OMEPRAZOLE; SULFOXIDES;

EID: 0037215257     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200301000-00021     Document Type: Letter

References (4)

1. Anonymous. Pantoprazole (Protonix). Med Lett Drugs Ther 2000;42:65-6.
2. Mossner J, Holscher AH, Herz R, et al. A double-blind study of pantoprazole and omeprazole in the treatment of reflux esophagitis: A multicenter trail. Aliment Pharmacol Ther 1995;9:321-6.
3. Ramirez-Barba EJ, et al. Low-dose pantoprazole (20 mg) is effective in the treatment of mild reflux oesophagitis. Clin Drug Invest 1999;18:445-51.
4. Metz DC, Pratha V, Martin P, et al. Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease. Am J Gastroenterol 2000;95:626-33.